{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:27:35Z","timestamp":1789230455904,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Clozapine may cause serious side effects despite benefits in patients with schizophrenia. Thus, an accurate understanding of the side-effect profile of clozapine is extremely important in the management of its administration to patients with schizophrenia. Our aim was to validate the relationship between clozapine exposure and appendicitis onset in patients with schizophrenia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we retrospectively compared the incidence and cumulative incidence of appendicitis in patients with schizophrenia with and without a history of clozapine exposure. Among the patients with schizophrenia who visited our hospital between June 2009 and August 2021, we extracted those with a history of clozapine treatment. Patients with a history of taking clozapine were defined as the clozapine exposure group, while the others were defined as the clozapine non-exposure group. Patients with a history of appendectomy before their initial visit to our hospital or with a history of clozapine use at other hospitals were excluded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 65 patients in the clozapine exposure group and 400 patients in the clozapine non-exposure group who met the inclusion criteria. The exposure group exhibited a remarkably higher incidence of appendicitis during the observation period than the non-exposure group (863 cases vs. 124 cases per 100,000 person-years). In particular, if limited to the period of clozapine exposure, the incidence of appendicitis is extremely high, at 2,086 cases per 100,000 person-years. Moreover, multivariable analysis showed that clozapine exposure was an independent factor contributing to the onset of appendicitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Clozapine exposure is associated with appendicitis onset in patients with schizophrenia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-022-04312-4","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T13:02:38Z","timestamp":1666357358000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Relationship between clozapine exposure and the onset of appendicitis in schizophrenia patients: a retrospective cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Yuta","family":"Kawakita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonari","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"issue":"10039","key":"4312_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","volume":"388","author":"MJ Owen","year":"2016","unstructured":"Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388(10039):86\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(15)01121-6.","journal-title":"Lancet."},{"issue":"2 Suppl","key":"4312_CR2","first-page":"1","volume":"161","author":"AF Lehman","year":"2004","unstructured":"Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, et al. American Psychiatric Association; Steering Committee on Practice Guidelines Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2 Suppl):1\u201356.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"4312_CR3","doi-asserted-by":"publisher","first-page":"18com12123","DOI":"10.4088\/JCP.18com12123","volume":"80","author":"JM Kane","year":"2019","unstructured":"Kane JM, Agid O, Baldwin ML, Howes O, Lindenmayer JP, Marder S, et al. Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia. J Clin Psychiatry. 2019;80(2):18com12123. https:\/\/doi.org\/10.4088\/JCP.18com12123.","journal-title":"J Clin Psychiatry."},{"issue":"3","key":"4312_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1007\/s13311-017-0552-9","volume":"14","author":"FC Nucifora Jr","year":"2017","unstructured":"Nucifora FC Jr, Mihaljevic M, Lee BJ, Sawa A. Clozapine as a Model for Antipsychotic Development. Neurotherapeutics. 2017;14(3):750\u201361. https:\/\/doi.org\/10.1007\/s13311-017-0552-9.","journal-title":"Neurotherapeutics."},{"issue":"3","key":"4312_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/acps.13111","volume":"141","author":"JM Rubio","year":"2020","unstructured":"Rubio JM, Kane JM. How and when to use clozapine. Acta Psychiatr Scand. 2020;141(3):178\u201389. https:\/\/doi.org\/10.1111\/acps.13111.","journal-title":"Acta Psychiatr Scand."},{"key":"4312_CR6","doi-asserted-by":"publisher","first-page":"702789","DOI":"10.3389\/fpsyt.2021.702789","volume":"12","author":"A Mariano","year":"2021","unstructured":"Mariano A, Di Lorenzo G, Jannini TB, Santini R, Bertinelli E, Siracusano A, et al. Medical Comorbidities in 181 Patients With Bipolar Disorder vs. Schizophrenia and Related Psychotic Disorders: Findings From a Single-Center, Retrospective Study From an Acute Inpatients Psychiatric Unit. Front Psychiatry. 2021;12:702789. https:\/\/doi.org\/10.3389\/fpsyt.2021.702789. eCollection 2021.","journal-title":"Front Psychiatry."},{"key":"4312_CR7","unstructured":"Ronald FM. Acute appendicitis in adults: Clinical manifestations and differential diagnosis. In: UpToDate, Post TW (Ed), UpToDate, Waltham, MA. [Online]. Available at: https:\/\/www.uptodate.com\/contents\/acute-appendicitis-in-adults-clinical-manifestations-and-differential-diagnosis?search=appendicitis&source=search_result&selectedTitle=2~150&usage_type=default&display_rank=2. Accessed 26 Mar 2022."},{"key":"4312_CR8","doi-asserted-by":"publisher","first-page":"j1703","DOI":"10.1136\/bmj.j1703","volume":"357","author":"DLH Baird","year":"2017","unstructured":"Baird DLH, Simillis C, Kontovounisios C, Rasheed S, Tekkis PP. Acute appendicitis. BMJ. 2017;357:j1703. https:\/\/doi.org\/10.1136\/bmj.j1703.","journal-title":"BMJ"},{"issue":"10000","key":"4312_CR9","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/S0140-6736(15)00275-5","volume":"386","author":"A Bhangu","year":"2015","unstructured":"Bhangu A, S\u00f8reide K, Di Saverio S, Assarsson JH, Drake FT. Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management. Lancet. 2015;386(10000):1278\u201387. https:\/\/doi.org\/10.1016\/S0140-6736(15)00275-5.","journal-title":"Lancet."},{"issue":"12","key":"4312_CR10","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1007\/s00268-012-1749-z","volume":"36","author":"JE Anderson","year":"2012","unstructured":"Anderson JE, Bickler SW, Chang DC, Talamini MA. Examining a common disease with unknown etiology: trends in epidemiology and surgical management of appendicitis in California, 1995\u20132009. World J Surg. 2012;36(12):2787\u201394. https:\/\/doi.org\/10.1007\/s00268-012-1749-z.","journal-title":"World J Surg."},{"key":"4312_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13017-015-0036-3","volume":"10","author":"KB Lin","year":"2015","unstructured":"Lin KB, Lai KR, Yang NP, Chan CL, Liu YH, Pan RH, et al. Epidemiology and socioeconomic features of appendicitis in Taiwan: a 12-year population-based study. World J Emerg Surg. 2015;10:42. https:\/\/doi.org\/10.1186\/s13017-015-0036-3. eCollection 2015.","journal-title":"World J Emerg Surg."},{"issue":"7","key":"4312_CR12","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s00268-021-06077-5","volume":"45","author":"DP Wickramasinghe","year":"2021","unstructured":"Wickramasinghe DP, Xavier C, Samarasekera DN. The Worldwide Epidemiology of Acute Appendicitis: An Analysis of the Global Health Data Exchange Dataset. World J Surg. 2021;45(7):1999\u20132008. https:\/\/doi.org\/10.1007\/s00268-021-06077-5.","journal-title":"World J Surg."},{"key":"4312_CR13","unstructured":"Kraepelin E. Dementia praecox and paraphrenia. Chicago Medical Book Co. 1919."},{"key":"4312_CR14","unstructured":"Bleuler E. Dementia praecox or the group of schizophrenias. International Universities Press. 1950."},{"issue":"1","key":"4312_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.amjsurg.2006.06.034","volume":"193","author":"BK Cooke","year":"2007","unstructured":"Cooke BK, Magas LT, Virgo KS, Feinberg B, Adityanjee A, Johnson FE. Appendectomy for appendicitis in patients with schizophrenia. Am J Surg. 2007;193(1):41\u20138. https:\/\/doi.org\/10.1016\/j.amjsurg.2006.06.034.","journal-title":"Am J Surg."},{"key":"4312_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/1471-2458-7-331","volume":"7","author":"JH Tsay","year":"2007","unstructured":"Tsay JH, Lee CH, Hsu YJ, Wang PJ, Bai YM, Chou YJ, et al. Disparities in appendicitis rupture rate among mentally ill patients. BMC Public Health. 2007;7:331. https:\/\/doi.org\/10.1186\/1471-2458-7-331.","journal-title":"BMC Public Health."},{"issue":"9","key":"4312_CR17","doi-asserted-by":"publisher","first-page":"e017150","DOI":"10.1136\/bmjopen-2017-017150","volume":"7","author":"Y Nishihira","year":"2017","unstructured":"Nishihira Y, McGill RL, Kinjo M. Perforated appendicitis in patients with schizophrenia: a retrospective cohort study. BMJ Open. 2017;7(9):e017150. https:\/\/doi.org\/10.1136\/bmjopen-2017-017150.","journal-title":"BMJ Open."},{"issue":"4","key":"4312_CR18","doi-asserted-by":"publisher","first-page":"20cr13841","DOI":"10.4088\/JCP.20cr13841","volume":"82","author":"T Steinert","year":"2021","unstructured":"Steinert T, Jans F. Six Cases of Perforated Appendicitis During Clozapine Treatment. J Clin Psychiatry. 2021;82(4):20cr13841. https:\/\/doi.org\/10.4088\/JCP.20cr13841.","journal-title":"J Clin Psychiatry."},{"key":"4312_CR19","volume-title":"Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition, Text Revision: DSM-4-TR","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition, Text Revision: DSM-4-TR. Washington: American Psychiatric Association; 1994."},{"key":"4312_CR20","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition: DSM-5","author":"American Psychological Association","year":"2013","unstructured":"American Psychological Association. Diagnostic and Statistical Manual of Mental Disorders - Fifth Edition: DSM-5. Arlington: American Psychiatric Association; 2013."},{"key":"4312_CR21","unstructured":"Clozaril\u00ae, Medication package insert. Novartis Pharmaceuticals Corporation: Tokyo, Japan, 2009. Update April 06, 2020."},{"key":"4312_CR22","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.2147\/NDT.S69784","volume":"10","author":"YS Kikuchi","year":"2014","unstructured":"Kikuchi YS, Sato W, Ataka K, Yagisawa K, Omori Y, Kanbayashi T, et al. Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia. Neuropsychiatr Dis Treat. 2014;10:1973\u20138. https:\/\/doi.org\/10.2147\/NDT.S69784. eCollection 2014.","journal-title":"Neuropsychiatr Dis Treat."},{"issue":"1","key":"4312_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/s1092-9134(00)90011-x","volume":"4","author":"NJ Carr","year":"2000","unstructured":"Carr NJ. The pathology of acute appendicitis. Ann Diagn Pathol. 2000;4(1):46\u201358. https:\/\/doi.org\/10.1016\/s1092-9134(00)90011-x.","journal-title":"Ann Diagn Pathol."},{"issue":"5","key":"4312_CR24","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/archsurg.1937.01190170056006","volume":"35","author":"SH Gray","year":"1937","unstructured":"Gray SH, Heifetz CJ. Lymphoid hyperplasia of the appendix with a note on its role in acute appendicitis. Arch Surg. 1937;35(5):887\u2013900. https:\/\/doi.org\/10.1001\/archsurg.1937.01190170056006.","journal-title":"Arch Surg."},{"issue":"3","key":"4312_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/wps.20567","volume":"17","author":"TS Stroup","year":"2018","unstructured":"Stroup TS, Gray N. Management of common adverse effects of antipsychotic medications. World Psychiatry. 2018;17(3):341\u201356. https:\/\/doi.org\/10.1002\/wps.20567.","journal-title":"World Psychiatry"},{"issue":"6","key":"4312_CR26","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3390\/ijms17060863","volume":"17","author":"A Shirazi","year":"2016","unstructured":"Shirazi A, Stubbs B, Gomez L, Moore S, Gaughran F, Flanagan RJ, et al. Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis. Int J Mol Sci. 2016;17(6):863. https:\/\/doi.org\/10.3390\/ijms17060863.","journal-title":"Int J Mol Sci."},{"issue":"2","key":"4312_CR27","doi-asserted-by":"publisher","first-page":"e100183","DOI":"10.1136\/gpsych-2019-100183","volume":"33","author":"J de Leon","year":"2020","unstructured":"de Leon J, Ruan CJ, Verdoux H, Wang C. Clozapine is strongly associated with the risk of pneumonia and inflammation. Gen Psychiatr. 2020;33(2):e100183. https:\/\/doi.org\/10.1136\/gpsych-2019-100183. eCollection 2020.","journal-title":"Gen Psychiatr."},{"key":"4312_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2019.07.040","volume":"211","author":"H Verdoux","year":"2019","unstructured":"Verdoux H, Quiles C, de Leon J. Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review. Schizophr Res. 2019;211:1\u20139. https:\/\/doi.org\/10.1016\/j.schres.2019.07.040.","journal-title":"Schizophr Res."},{"issue":"3","key":"4312_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00213-022-06067-y","volume":"239","author":"X Yuan","year":"2022","unstructured":"Yuan X, Wang S, Shi Y, Yang Y, Zhang Y, Xia L, et al. Pro-inflammatory cytokine levels are elevated in female patients with schizophrenia treated with clozapine. Psychopharmacology (Berl). 2022;239(3):765\u201371. https:\/\/doi.org\/10.1007\/s00213-022-06067-y.","journal-title":"Psychopharmacology (Berl)."},{"issue":"6","key":"4312_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/pcn.12508","volume":"71","author":"YP Hung","year":"2017","unstructured":"Hung YP, Wang CS, Yen CN, Chang HC, Chen PS, Lee IH, et al. Role of cytokine changes in clozapine-induced fever: A cohort prospective study. Psychiatry Clin Neurosci. 2017;71(6):395\u2013402. https:\/\/doi.org\/10.1111\/pcn.12508.","journal-title":"Psychiatry Clin Neurosci."},{"issue":"7","key":"4312_CR31","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70(7):663\u201371. https:\/\/doi.org\/10.1016\/j.biopsych.2011.04.013.","journal-title":"Biol Psychiatry."},{"issue":"8","key":"4312_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","volume":"63","author":"S Potvin","year":"2008","unstructured":"Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008;63(8):801\u20138. https:\/\/doi.org\/10.1016\/j.biopsych.2007.09.024.","journal-title":"Biol Psychiatry."},{"issue":"1\u20133","key":"4312_CR33","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","volume":"155","author":"R Upthegrove","year":"2014","unstructured":"Upthegrove R, Manzanares-Teson N, Barnes NM. Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res. 2014;155(1\u20133):101\u20138. https:\/\/doi.org\/10.1016\/j.schres.2014.03.005.","journal-title":"Schizophr Res."},{"issue":"4","key":"4312_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.30773\/pi.2018.12.16","volume":"16","author":"YS Kikuchi","year":"2018","unstructured":"Kikuchi YS, Kanbayashi T, Shimizu T. Relationship between Clozapine-Induced Electroencephalogram Abnormalities and Serum Concentration of Clozapine in Japanese Patients with Treatment-Resistant Schizophrenia. Psychiatry Investig. 2018;16(4):279\u201384. https:\/\/doi.org\/10.30773\/pi.2018.12.16.","journal-title":"Psychiatry Investig."},{"issue":"2","key":"4312_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0006-3223(96)00298-3","volume":"42","author":"O Freudenreich","year":"1997","unstructured":"Freudenreich O, Weiner RD, McEvoy JP. Clozapine-induced electroencephalogram changes as a function of clozapine serum levels. Biol Psychiatry. 1997;42(2):132\u20137. https:\/\/doi.org\/10.1016\/S0006-3223(96)00298-3.","journal-title":"Biol Psychiatry."},{"issue":"4","key":"4312_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/145749690709600405","volume":"96","author":"E Ergul","year":"2007","unstructured":"Ergul E. Heredity and familial tendency of acute appendicitis. Scand J Surg. 2007;96(4):290\u20132. https:\/\/doi.org\/10.1177\/145749690709600405.","journal-title":"Scand J Surg."},{"issue":"7","key":"4312_CR37","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/ajmg.b.32652","volume":"177","author":"DS Tylee","year":"2018","unstructured":"Tylee DS, Sun J, Hess JL, Tahir MA, Sharma E, Malik R, et al. Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data. Am J Med Genet B Neuropsychiatr Genet. 2018;177(7):641\u201357. https:\/\/doi.org\/10.1002\/ajmg.b.32652.","journal-title":"Am J Med Genet B Neuropsychiatr Genet."},{"issue":"1","key":"4312_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12821","volume":"186","author":"IA Kooij","year":"2016","unstructured":"Kooij IA, Sahami S, Meijer SL, Buskens CJ, Te Velde AA. The immunology of the vermiform appendix: a review of the literature. Clin Exp Immunol. 2016;186(1):1\u20139. https:\/\/doi.org\/10.1111\/cei.12821.","journal-title":"Clin Exp Immunol."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04312-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-022-04312-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04312-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T13:02:47Z","timestamp":1666357367000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-022-04312-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["4312"],"URL":"https:\/\/doi.org\/10.1186\/s12888-022-04312-4","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"18 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective cohort study was approved by the ethics committee of Akita University (approval number: 2762). All methods in the present study were carried out in accordance with relevant guidelines and regulations and the ethical standards laid down in the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from all the study subjects in the form of opt-out on the website and approved by the ethics committee of Akita University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Masahiro Takeshima has received speaker\u2019s honoraria from Takeda Pharmaceutical, MSD, Daiichi Sankyo Company, Sumitomo Dainippon Pharma, Meiji Seika Pharma, Viatris Pharmaceuticals Japan, and Yoshitomi Pharmaceutical, and research grants from Otsuka Pharmaceutical, EISAI, Shionogi and the Japanese Ministry of Health, Labour and Welfare (R3-21GC1016) outside the submitted work. Kazuo Mishima has received speaker\u2019s honoraria from EISAI Co., Ltd., Nobelpharma Co., Ltd., and MSD Inc., and research grants from the Japanese Ministry of Health, Labour and Welfare (19GC1012, 21GC0801) outside the submitted work. The other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"653"}}